Serum levels of advanced glycation end products (ages) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects
Cardiovascular Therapeutics, 05/01/2012
Ueda S et al. – This study demonstrated for the first time that the serum level of AGEs was one of the independent correlates of decreased cell number and impaired migratory activity of circulating endothelial progenitor cells (EPCs) in apparently healthy subjects. This present observations suggest that even in young healthy subjects, serum level of AGEs may be a biomarker that could predict the progression of atherosclerosis and future cardiovascular events.
